ArticleJournal of chemical information and modeling2026
More Accurate Binding Affinity Prediction Using Protein Homology and Ligand-Based Transfer Learning.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Accurate and rapid prediction of protein-ligand binding affinities is critical for drug discovery, particularly when evaluating large chemical libraries or new drug molecules from high-throughput generative models. We present UCBbind, a hybrid framework that combines a similarity-based transfer module with a deep-learning-based prediction module, to efficiently estimate binding affinities of small molecules to target proteins. For each query protein-ligand pair, UCBbind transfers experimental data from highly similar reference pairs when available and applies the prediction module when no sufficiently similar reference exists. We benchmarked UCBbind on multiple datasets, including the CASF-2016 set, the HiQBind dataset post 2020, and the COVID Moonshot database. Our results show that UCBbind achieves state-of-the-art predictive performance, particularly for test entries with high similarity to well-characterized reference proteins and ligands, and can support downstream tasks such as binding site prediction and binder/nonbinder classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.